Dupilumab Reduces Urticaria Activity, Itch, and Hives in Patients with Chronic Spontaneous Urticaria Regardless of Baseline Serum Immunoglobulin E Levels.
Marcus MaurerThomas B CasaleSarbjit S SainiMoshe Ben-ShoshanElizabeth LawsJennifer MaloneyDeborah BauerAllen RadinMelanie MakhijaPublished in: Dermatology and therapy (2024)
ClinicalTrials.gov Identifier: NCT04180488.
Keyphrases